NSF Gaps-to-Graphs (SPOKE)
NSF Proto-OKNBeginnerEnded

NSF Gaps-to-Graphs (SPOKE)

“⭐ Enhance and Accelerate Healthcare Drug Discovery with AI Knowledge”

The Challenge

What you'll do: • Research and analyze the problem space • Explore gaps in AI-powered data models • Present your approach with a proposal for sources and how to fix the gap What you'll deliver: A list of gaps + options to remedy. Why it matters: Your Challenge: Enhance +20% and Accelerate x10 AI Research’s Impact on Supply Chains For an hour, attendants will help Proto-OKN projects transition to markets, by co-piloting data enhancement solutions for their Knowledge Graphs. Developing AI requires both technical and domain/business leaders to collaborate. NO TECHNICAL SKILLS NEEDED

Timeline

NSF Gaps to Graphs SPOKE - Co-creation session

Mentor Session

Thu, May 28, 2026

This is when we will gather, test, and co-create.

About This Challenge

Discover and address critical gaps in biomedical knowledge to accelerate drug discovery, improve therapeutic predictions, and enhance coordinated research across pharmaceutical networks. This master-level challenge focuses specifically on the SPOKE Knowledge Graph - UCSF's comprehensive biomedical AI system mapping relationships between diseases, drugs, genes, proteins, and biological pathways into an interconnected knowledge network within the Proto-OKN framework. You'll work directly with drug discovery researchers and pharmaceutical practitioners to identify where this knowledge system falls short and develop strategies to fill those gaps. ## What You'll Explore The SPOKE Knowledge Graph captures critical intelligence about: - Drug-target interactions, mechanism of action pathways, and therapeutic efficacy patterns across disease contexts - Molecular pathway optimization and biomarker identification in complex disease networks - Adverse event propagation models and drug safety assessment across patient populations - Clinical trial coordination protocols and patient stratification during drug development - Biomarker validation workflows and therapeutic response tracking across research partnerships - Precision medicine integration and treatment personalization strategies Your Mission: Identify where this research-grade knowledge graph has gaps in knowledge or impact, and develop practical options to remedy these deficiencies affecting both pharmaceutical companies and their research collaborators. ## The Drug Discovery Knowledge Challenge Current biomedical knowledge systems face significant limitations: - Siloed Research Data: Critical molecular interaction data and clinical outcomes remain isolated across laboratory information systems, clinical databases, and research platforms - Discovery Delays: Drug researchers and clinical teams lack real-time access to validated targets, biomarker correlations, and patient stratification insights - Predictability Blind Spots: Disconnected systems miss early efficacy signals and safety patterns that could accelerate or prevent drug development failures - Collaboration Failures: Knowledge systems struggle to support the complex multi-institutional partnerships required for effective drug discovery and development The SPOKE Knowledge Graph within Proto-OKN aims to address these issues, but needs expert analysis to identify blind spots and enhancement opportunities. ## Your Analytical Role No technical experience required - we need your biomedical domain expertise and research insight. You'll work in focused teams including: - SPOKE Knowledge Graph researchers and computational biologists - Pharmaceutical scientists and drug discovery specialists - Clinical researchers and translational medicine experts - Biomarker specialists and precision medicine practitioners - Regulatory affairs professionals and clinical trial coordinators - Academic collaborators and industry research partners Together, you'll: 1. Identify Knowledge Gaps: Pinpoint what critical biomedical information is missing or inadequately represented in drug discovery pathways 2. Assess Research Coordination Failures: Determine where the knowledge graph fails to support effective multi-institutional collaboration 3. Develop Integration Solutions: Design practical approaches to connect SPOKE with existing laboratory systems, clinical databases, and pharmaceutical research platforms 4. Prioritize Enhancement Opportunities: Rank gap-filling strategies by impact on drug discovery timelines and therapeutic success rates 5. Map Implementation Pathways: Connect gap analysis to actionable improvement roadmaps for pharmaceutical researchers and clinical teams ## Real Impact Potential Your contributions will directly influence: - Enhanced Drug Target Validation: Improved data integration enabling faster identification of promising therapeutic targets - Better Research Coordination: Connected systems reducing duplicate efforts and missed collaboration opportunities across institutions - Stronger Predictive Models: More complete knowledge improving drug efficacy predictions and patient stratification - Accelerated Discovery: Better biomedical intelligence and research coordination reducing time-to-market for life-saving therapeutics ## Success Metrics Core Deliverables: - Comprehensive gap inventory identifying knowledge and coordination deficiencies in drug discovery systems - Prioritized remediation options with implementation feasibility assessments for pharmaceutical and academic researchers - Integration analysis quantifying how gap-filling improves drug discovery success rates and research efficiency - Actionable roadmap for SPOKE Knowledge Graph enhancement tailored to pharmaceutical research networks Broader Impact: - Drug researchers gain comprehensive access to validated molecular interactions and therapeutic pathway insights - Clinical teams access critical biomarker correlations improving patient stratification and trial design outcomes - Pharmaceutical companies coordinate more effectively across research partnerships reducing development risks and costs - Healthcare organizations make data-driven decisions about therapeutic investments, precision medicine strategies, and research collaborations ## Getting Started Come prepared to share your expertise about drug discovery challenges, research coordination gaps, and data limitations in your domain. Whether you work in pharmaceutical research, clinical trials, computational biology, precision medicine, regulatory affairs, or biomedical analytics - your perspective is essential for identifying where our knowledge systems fall short. Biomedical knowledge gaps perpetuate drug development failures and limit therapeutic breakthroughs. Join us to find them and fix them.

Research Team

Principal Investigator: Dr. Sergio Baranzini, Professor of Neurology, and the SPOKE Proto-OKN collaborative research team developing the Scalable Precision Medicine Open Knowledge Engine under the NSF Proto-OKN initiative. ## The SPOKE Proto-OKN Research Initiative This challenge connects you directly with cutting-edge research funded through NSF's Prototype Open Knowledge Network program - a multi-million dollar initiative to create interconnected knowledge systems that address critical societal challenges. The SPOKE project specifically targets biomedical knowledge fragmentation and drug discovery inefficiencies through advanced knowledge graph technologies that integrate heterogeneous biological data with clinical insights. ### Research Team Expertise Lead Research Group: Dr. Sergio Baranzini's SPOKE team at UCSF brings together specialists in: - Biomedical Knowledge Systems: Advanced ontology development and semantic modeling for complex biological networks and disease mechanisms - Drug-Target Integration: Multi-scale integration of molecular interactions, pathway networks, and therapeutic response patterns across diverse patient populations - Computational Biology: Data fusion across genomics platforms, clinical databases, pharmaceutical repositories, and biomedical literature - Knowledge Graph Engineering: Scalable graph architectures for complex biomedical relationship mapping, reasoning, and drug repurposing discovery ### Multi-Institutional Proto-OKN Collaboration The SPOKE Proto-OKN represents a convergence research approach, integrating: Technical Partners: - Biomedical informatics researchers developing drug-disease knowledge representation standards - Computational biologists specializing in molecular network analysis and pathway optimization - Data science experts focused on real-time biomedical knowledge graph updating and federated query processing - Clinical research teams working on precision medicine protocols and therapeutic response prediction models Industry Partners: - Pharmaceutical companies and biotechnology firms across drug discovery pipelines - Clinical research organizations and contract research platforms - Healthcare systems and academic medical centers with clinical trial capabilities - Regulatory science teams and drug safety monitoring organizations ### Research Innovation Focus The SPOKE team is pioneering scalable precision medicine knowledge integration that can: - Accelerate drug repurposing by identifying novel therapeutic applications through comprehensive biomedical relationship analysis - Predict adverse drug events by analyzing molecular pathway interactions and patient-specific risk factors across population-scale datasets - Enable precision therapeutic strategies through integrated genomic, clinical, and pharmacological knowledge reasoning - Facilitate coordinated research efforts while maintaining competitive boundaries and patient privacy protections across pharmaceutical networks ### Your Role in Active Proto-OKN Research As a challenge participant, you're not just analyzing biomedical data - you're contributing to live NSF-funded Proto-OKN development that will establish national biomedical knowledge infrastructure. Your gap analysis and remediation strategies will directly inform how the SPOKE system evolves to serve researchers, clinicians, and pharmaceutical developers nationwide. This is applied research with immediate clinical impact, where your insights help strengthen the foundational knowledge network supporting American biomedical innovation and therapeutic discovery through better integration of biological knowledge and clinical evidence.

Resources

### Public Biomedical Knowledge Repositories • NCBI Gene Expression Omnibus (GEO) - Comprehensive gene expression datasets across diseases, tissues, and treatment conditions for pathway analysis - https://www.ncbi.nlm.nih.gov/geo/ • UniProt Protein Knowledge Base - Detailed protein function annotations, molecular interactions, and disease associations - https://www.uniprot.org/ • Reactome Pathway Database - Curated biological pathways with molecular interactions and disease connections - https://reactome.org/ • KEGG Pathway Database - Metabolic pathways, drug-target networks, and disease pathway mapping - https://www.genome.jp/kegg/ • Gene Ontology Consortium - Standardized gene function annotations and biological process classifications - http://geneontology.org/ • Human Phenotype Ontology (HPO) - Standardized vocabulary for phenotypic abnormalities and disease characteristics - https://hpo.jax.org/ • OMIM (Online Mendelian Inheritance in Man) - Comprehensive genetic disorder catalog with gene-disease relationships - https://www.omim.org/ ### Drug Discovery and Chemical Data • ChEMBL Database - Bioactive molecules, drug targets, and pharmacological activity data from literature - https://www.ebi.ac.uk/chembl/ • DrugBank - Comprehensive drug data including targets, interactions, pharmacokinetics, and mechanisms - https://go.drugbank.com/ • PubChem - Chemical structures, bioactivity data, and molecular property information - https://pubchem.ncbi.nlm.nih.gov/ • Therapeutic Target Database (TTD) - Known and explored therapeutic protein and nucleic acid targets - http://db.idrblab.net/ttd/ • OpenTargets Platform - Target-disease associations with evidence from genetics, literature, and clinical data - https://www.opentargets.org/ • ClinicalTrials.gov API - Clinical trial protocols, outcomes, and drug development pipeline data - https://clinicaltrials.gov/api/ ### Molecular Interaction Networks • STRING Database - Protein-protein interaction networks with functional association evidence - https://string-db.org/ • BioGRID - Curated biological interactions including protein, genetic, and chemical interactions - https://thebiogrid.org/ • IntAct Molecular Interaction Database - Literature-curated molecular interactions with experimental evidence - https://www.ebi.ac.uk/intact/ • MINT Database - Experimentally verified protein-protein interactions from peer-reviewed publications - https://mint.bio.uniroma2.it/ • Pathway Commons - Integrated pathway data from multiple sources including BioPAX format networks - https://www.pathwaycommons.org/ ### Clinical and Healthcare Data Sources • FDA Adverse Event Reporting System (FAERS) - Post-market drug safety surveillance and adverse event patterns - https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers • ClinVar - Genomic variation and clinical significance for precision medicine applications - https://www.ncbi.nlm.nih.gov/clinvar/ • PharmGKB - Pharmacogenomic knowledge linking genetic variation to drug response - https://www.pharmgkb.org/ • SIDER Database - Drug side effects and adverse drug reactions from package inserts and literature - http://sideeffects.embl.de/ • COSMIC Cancer Database - Somatic mutations in cancer with therapeutic relevance and drug sensitivity data - https://cancer.sanger.ac.uk/cosmic ### Real-Time Biomedical APIs • PubMed API (E-utilities) - Real-time access to biomedical literature for knowledge discovery and validation - https://www.ncbi.nlm.nih.gov/books/NBK25497/ • Europe PMC REST API - Full-text biomedical literature mining and citation network analysis - https://europepmc.org/RestfulWebService • NCBI Entrez API - Programmatic access to genomic databases, protein sequences, and molecular data - https://www.ncbi.nlm.nih.gov/books/NBK25501/ • EBI Web Services - Unified access to EMBL-EBI's protein, genomic, and chemical databases - https://www.ebi.ac.uk/Tools/webservices/ ### Specialized Biomedical Platforms • Cypher System Neo4j SPOKE Instance - Direct query access to SPOKE's existing knowledge graph structure and relationships - Available through UCSF collaboration agreements • BioThings APIs - Unified APIs for gene, variant, chemical, and disease data integration - https://biothings.io/ • Monarch Initiative - Cross-species phenotype and disease data with standardized ontologies - https://monarchinitiative.org/ • DisGeNET - Gene-disease associations from curated repositories and literature mining - https://www.disgenet.org/ • CTD (Comparative Toxicogenomics Database) - Chemical-gene interactions, disease relationships, and environmental health data - http://ctdbase.org/ ### Pharmaceutical Industry Data • GDSC (Genomics of Drug Sensitivity in Cancer) - Drug screening data across cancer cell lines with genomic characterization - https://www.cancerrxgene.org/ • DepMap (Cancer Dependency Map) - CRISPR screens and drug sensitivity data for cancer target identification - https://depmap.org/portal/ • PhRMA Research Database - Pharmaceutical research investment patterns and drug development timelines - https://

Skills

You'll Learn

Data AnalysisStrategic PlanningPresentation SkillsSoftware DevelopmentRequirements GatheringStakeholder ManagementDisruptive InnovationBusiness AnalysisOpen Innovation

Helpful to Have

Outcomes Research

Tags

#Healthcare#Drug Discovery#Pharmaceuticals#SPOKE#nsf-partnership#proto-okn#frink-query-service#ai-research-transition#knowledge-graphs#renci-unc#industry-collaboration#cybersecurity-securechain#biomedical-spoke#open-knowledge-network#research-acceleration#ai-knowledge-systems#data-science-analytics#query-federation#supply-chain-security#ucsf-spoke#purdue-hcss#remote-breakout#march-2026#research-to-market
Hugo

Hosted by

Hugo

0 teams / 50 max
Starts May 28, 2026, 1:00 PM (EDT)
Ends May 28, 2026, 2:00 PM (EDT)

Leaderboard

Prizes

  • Certificates, Badges.